Literature DB >> 10906229

Characterization of a novel respiratory syncytial virus-specific human cytotoxic T-lymphocyte epitope.

P J Goulder1, F Lechner, P Klenerman, K McIntosh, B D Walker.   

Abstract

Respiratory syncytial virus (RSV) infection is a major cause of morbidity in childhood worldwide. The first human RSV-specific cytotoxic T-lymphocyte epitope to be defined is described. This HLA B7-restricted epitope in nucleoprotein (NP) was detectable in four healthy, B7-positive adult subjects using B7-RSV-NP tetrameric complexes to stain CD8(+) T cells.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10906229      PMCID： PMC112296          DOI： 10.1128/jvi.74.16.7694-7697.2000

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  22 in total

1.  Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus.

Authors:  K L Yap; G L Ada; I F McKenzie
Journal:  Nature       Date:  1978-05-18       Impact factor: 49.962

2.  The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection.

Authors:  P J Openshaw; K Anderson; G W Wertz; B A Askonas
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

3.  Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins.

Authors:  J A Nicholas; K L Rubino; M E Levely; E G Adams; P L Collins
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

4.  Human cytotoxic T cells stimulated by antigen on dendritic cells recognize the N, SH, F, M, 22K, and 1b proteins of respiratory syncytial virus.

Authors:  A H Cherrie; K Anderson; G W Wertz; P J Openshaw
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

5.  Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis.

Authors:  D Isaacs; C R Bangham; A J McMichael
Journal:  Lancet       Date:  1987-10-03       Impact factor: 79.321

6.  Cytotoxic T-cell immunity to influenza.

Authors:  A J McMichael; F M Gotch; G R Noble; P A Beare
Journal:  N Engl J Med       Date:  1983-07-07       Impact factor: 91.245

7.  Respiratory syncytial viral infection in children with compromised immune function.

Authors:  C B Hall; K R Powell; N E MacDonald; C L Gala; M E Menegus; S C Suffin; H J Cohen
Journal:  N Engl J Med       Date:  1986-07-10       Impact factor: 91.245

8.  Human and murine cytotoxic T cells specific to respiratory syncytial virus recognize the viral nucleoprotein (N), but not the major glycoprotein (G), expressed by vaccinia virus recombinants.

Authors:  C R Bangham; P J Openshaw; L A Ball; A M King; G W Wertz; B A Askonas
Journal:  J Immunol       Date:  1986-12-15       Impact factor: 5.422

9.  Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children.

Authors:  P J Goulder; Y Tang; C Brander; M R Betts; M Altfeld; K Annamalai; A Trocha; S He; E S Rosenberg; G Ogg; C A O'Callaghan; S A Kalams; R E McKinney; K Mayer; R A Koup; S I Pelton; S K Burchett; K McIntosh; B D Walker
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

10.  Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus.

Authors:  M J Cannon; P J Openshaw; B A Askonas
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307
View more
  20 in total

1.  The viral transcription group determines the HLA class I cellular immune response against human respiratory syncytial virus.

Authors:  Carolina Johnstone; Elena Lorente; Alejandro Barriga; Eilon Barnea; Susana Infantes; François A Lemonnier; Chella S David; Arie Admon; Daniel López
Journal:  Mol Cell Proteomics       Date:  2015-01-29       Impact factor: 5.911

2.  Serologic cross-reactions between nucleocapsid proteins of human respiratory syncytial virus and human metapneumovirus.

Authors:  Yange Zhang; Jan Pohl; W Abdullah Brooks; Dean D Erdman
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

3.  Identification of potential human respiratory syncytial virus and metapneumovirus T cell epitopes using computational prediction and MHC binding assays.

Authors:  Michael T Rock; Brett A McKinney; Sandra M Yoder; Catherine E Prudom; David W Wright; James E Crowe
Journal:  J Immunol Methods       Date:  2011-08-11       Impact factor: 2.303

4.  Vaccine-elicited CD8+ T cells protect against respiratory syncytial virus strain A2-line19F-induced pathogenesis in BALB/c mice.

Authors:  Sujin Lee; Kate L Stokes; Michael G Currier; Kaori Sakamoto; Nicholas W Lukacs; Esteban Celis; Martin L Moore
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

5.  Identification of the immunodominant H-2K(k)-restricted cytotoxic T-cell epitope in the Borna disease virus nucleoprotein.

Authors:  K Schamel; P Staeheli; J Hausmann
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Identification of a novel human leucocyte antigen-A*01-restricted cytotoxic T-lymphocyte epitope in the respiratory syncytial virus fusion protein.

Authors:  Michael T Rock; James E Crowe
Journal:  Immunology       Date:  2003-04       Impact factor: 7.397

Review 7.  Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.

Authors:  Matthew R Olson; Steven M Varga
Journal:  Expert Rev Vaccines       Date:  2008-10       Impact factor: 5.217

8.  Identification of a common HLA-DP4-restricted T-cell epitope in the conserved region of the respiratory syncytial virus G protein.

Authors:  L de Waal; S Yüksel; A H Brandenburg; J P M Langedijk; K Sintnicolaas; G M G M Verjans; A D M E Osterhaus; R L de Swart
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

9.  Recognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes.

Authors:  Ruth M Gaddum; Roy S Cook; Julie M Furze; Shirley A Ellis; Geraldine Taylor
Journal:  Immunology       Date:  2003-02       Impact factor: 7.397

10.  Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.

Authors:  Christopher A Green; Elisa Scarselli; Charles J Sande; Amber J Thompson; Catherine M de Lara; Kathryn S Taylor; Kathryn Haworth; Mariarosaria Del Sorbo; Brian Angus; Loredana Siani; Stefania Di Marco; Cinzia Traboni; Antonella Folgori; Stefano Colloca; Stefania Capone; Alessandra Vitelli; Riccardo Cortese; Paul Klenerman; Alfredo Nicosia; Andrew J Pollard
Journal:  Sci Transl Med       Date:  2015-08-12       Impact factor: 17.956
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.